PTCHF (PureTech Health) Operating Cash Flow per Share : $-0.52 (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is PureTech Health Operating Cash Flow per Share?

PureTech Health's operating cash flow per share for the six months ended in Dec. 2024 was $-0.22. PureTech Health's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.52.

During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -6.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -21.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for PureTech Health's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, PureTech Health's highest 3-Year average Operating Cash Flow per Share Growth Rate was 3.30% per year. The lowest was -195.30% per year. And the median was -26.10% per year.

PTCHF's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

PureTech Health Operating Cash Flow per Share Historical Data

The historical data trend for PureTech Health's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health Operating Cash Flow per Share Chart

PureTech Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.45

-0.55

-0.63

-0.38

-0.53

PureTech Health Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.33	-0.23	-0.15	-0.30	-0.22

Competitive Comparison of PureTech Health's Operating Cash Flow per Share

For the Biotechnology subindustry, PureTech Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PureTech Health's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PureTech Health's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PureTech Health's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

PureTech Health Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

PureTech Health's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-134.369	/	256.028
	=	-0.52

PureTech Health's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-54.355	/	242.399
	=	-0.22

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.52

PureTech Health Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of PureTech Health's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PureTech Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (OTCPK:PTCHF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

PRTC:USA PRTCl:UK PRTC:UK 0VQ:Germany

Address

6 Tide Street, Suite 400, Boston, MA, USA, 02210

Website

https://www.puretechhealth.com

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.